Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Spondyloarthritis
•
Interstitial lung disease
•
Psoriatic arthritis
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
Do you routinely screen for interstitial lung disease in patients with psoriatic arthritis?
Related Questions
How do you manage pleuroparenchymal fibroelastosis in a patient with seronegative RA that is progressing on Rituxan and DMARD therapy?
How frequently do you monitor CT scans, PFTs, and TTEs in patients with ILA or mild ILD?
Do you seek pathologic confirmation before proceeding with empiric immunosuppressive therapy in symptomatic patients with radiographic NSIP?
Is it still significant to denote the etiology of ILD in a patient with PPF?
How do you approach management of chronic cough in patients with ILD?
How do you approach inflammatory arthralgias without synovitis in a patient with psoriasis?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
